Riccardo Perfetti
CIK 1775410 · Chief Medical Officer · last filed 2025-03-06
Riccardo Perfetti is a Chief Medical Officer who has filed 38 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing shows the insider sold $4.6K of APLT on Mar 6, 2025. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
APLT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
340 MADISON AVENUE, 19TH FLOOR
NEW YORK, NY 10173
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Applied Therapeutics, Inc. (APLT) Delisted | Chief Medical Officer | 890,409 | $0.10 | $91.7K | -$2.72M | 38 | 2025-03-06 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-06 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −10,366 | -$4.6K | EDGAR |
| 2025-02-07 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −86,078 | -$52.5K | EDGAR |
| 2024-08-23 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −22,681 | -$132.2K | EDGAR |
| 2024-06-10 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −22,003 | -$95.1K | EDGAR |
| 2024-03-18 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −110,804 | -$597.2K | EDGAR |
| 2023-12-22 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | +450,000 | $0 | EDGAR |
| 2023-12-01 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −1,583 | -$3.1K | EDGAR |
| 2023-09-29 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −10,932 | -$29.5K | EDGAR |
| 2023-01-13 | Applied Therapeutics, Inc. (APLT) Delisted | Mixed | +543,947 | -$5.5K | EDGAR |
| 2022-08-04 | Applied Therapeutics, Inc. (APLT) Delisted | Disp (D) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.